UCSC Human Gene Sorter
 
genome assembly search
sort by display output 
#
Name
VisiGene
BLASTP
E-Value
Genome Position
Description
1PAX5n/a
n/a
n/a
n/a
0chr9 36,933,768paired box 5, transcript variant 12 (from RefSeq NR_103999.2)
2CD226n/a
n/a
n/a
n/a
n/achr18 69,900,573CD226 molecule, transcript variant 2 (from RefSeq NM_001303618.2)
3TLR10n/a
n/a
n/a
n/a
n/achr4 38,777,614toll like receptor 10, transcript variant 1 (from RefSeq NM_030956.4)
4AICDAn/a
n/a
n/a
n/a
n/achr12 8,607,514activation induced cytidine deaminase, transcript variant 1 (from RefSeq NM_020661.4)
5P2RY10n/a
n/a
n/a
n/a
n/achrX 78,954,559P2Y receptor family member 10, transcript variant 1 (from RefSeq NM_014499.4)
6CD80n/a
n/a
n/a
n/a
n/achr3 119,541,953CD80 molecule (from RefSeq NM_005191.4)
7STAP1n/a
n/a
n/a
n/a
n/achr4 67,583,032signal transducing adaptor family member 1, transcript variant 1 (from RefSeq NM_012108.4)
8BTLAn/a
n/a
n/a
n/a
n/achr3 112,481,719B and T lymphocyte associated, transcript variant 1 (from RefSeq NM_181780.4)
9LINC00996n/a
    
    
     
n/achr7 150,440,897long intergenic non-protein coding RNA 996 (from RefSeq NR_034033.1)
10TBC1D27Pn/a
n/a
n/a
n/a
n/achr17 16,928,250TBC1 domain family member 27, pseudogene (from HGNC TBC1D27P)
11ENSG00000290698n/a
n/a
n/a
n/a
n/achr17 16,928,877TBC1 domain family member 27, pseudogene (from RefSeq NR_147084.1)
12IGHV1OR15-1n/a
    
    
     
n/achr15 22,160,649Immunoglobulins are composed of two identical heavy chains and  two identical light chains; disulfide-linked. (from UniProt A0A075B7D0)
13FCRL5n/a
n/a
n/a
n/a
n/achr1 157,532,946Fc receptor like 5, transcript variant 1 (from RefSeq NM_031281.3)
14IKZF3n/a
n/a
n/a
n/a
n/achr17 39,811,015IKAROS family zinc finger 3, transcript variant 1 (from RefSeq NM_012481.5)
15SPNn/a
n/a
n/a
n/a
n/achr16 29,667,061sialophorin, transcript variant 2 (from RefSeq NM_003123.6)
16IL21Rn/a
n/a
n/a
n/a
n/achr16 27,427,108interleukin 21 receptor, transcript variant 2 (from RefSeq NM_181078.3)
17ENSG00000269954n/a
    
    
     
n/achr8 11,558,591ENSG00000269954 (from geneSymbol)
18PNOCn/a
n/a
n/a
n/a
n/achr8 28,330,309prepronociceptin, transcript variant 1 (from RefSeq NM_006228.5)
19TNFRSF8n/a
n/a
n/a
n/a
n/achr1 12,103,755TNF receptor superfamily member 8, transcript variant 1 (from RefSeq NM_001243.5)
20TNFRSF17n/a
n/a
n/a
n/a
n/achr16 11,966,639TNF receptor superfamily member 17 (from RefSeq NM_001192.3)
21FAM111Bn/a
n/a
n/a
n/a
n/achr11 59,117,324FAM111 trypsin like peptidase B, transcript variant 1 (from RefSeq NM_198947.4)
22PCLAFn/a
n/a
n/a
n/a
n/achr15 64,372,872PCNA clamp associated factor, transcript variant 1 (from RefSeq NM_014736.6)
23ENSG00000259316n/a
n/a
n/a
n/a
n/achr15 64,297,759Cytoplasm, perinuclear region   Nucleus (from UniProt A0A0U1RQM0)
24LINC02397n/a
    
    
     
n/achr12 92,479,271long intergenic non-protein coding RNA 2397 (from HGNC LINC02397)
25CLLU1n/a
n/a
n/a
n/a
n/achr12 92,426,259chronic lymphocytic leukemia up-regulated 1, transcript variant 2 (from RefSeq NR_027932.1)
26ENSG00000266923n/a
n/a
n/a
n/a
n/achr12 92,452,605ENSG00000266923 (from geneSymbol)
27MKI67n/a
n/a
n/a
n/a
n/achr10 128,111,541marker of proliferation Ki-67, transcript variant 1 (from RefSeq NM_002417.5)
28TLR7n/a
    
    
     
n/achrX 12,878,716toll like receptor 7 (from RefSeq NM_016562.4)
29IGHV5-78n/a
    
    
     
n/achr14 106,851,270immunoglobulin heavy variable 5-78 (pseudogene) (from HGNC IGHV5-78)
30CNR2n/a
n/a
n/a
n/a
n/achr1 23,891,938cannabinoid receptor 2 (from RefSeq NM_001841.3)
31ADGRG5n/a
n/a
n/a
n/a
n/achr16 57,559,916adhesion G protein-coupled receptor G5, transcript variant 3 (from RefSeq NM_001318481.2)
32RHOHn/a
n/a
n/a
n/a
n/achr4 40,221,999ras homolog family member H, transcript variant 6 (from RefSeq NM_004310.5)
33ENSG00000260997n/a
    
    
     
n/achr7 44,959,954ENSG00000260997 (from geneSymbol)
34WNT10An/a
n/a
n/a
n/a
n/achr2 218,887,390Wnt family member 10A (from RefSeq NM_025216.3)
35DLGAP5n/a
n/a
n/a
n/a
n/achr14 55,169,860DLG associated protein 5, transcript variant 1 (from RefSeq NM_014750.5)
36ENSG00000253690n/a
    
    
     
n/achr8 28,294,659ENSG00000253690 (from geneSymbol)
37RPL7AP75n/a
    
    
     
n/achr15 59,407,558RPL7AP75 (from geneSymbol)
38TNFn/a
    
    
     
n/achr6 31,576,950tumor necrosis factor (from RefSeq NM_000594.4)
39TMEM156n/a
    
    
     
n/achr4 38,999,576transmembrane protein 156, transcript variant 1 (from RefSeq NM_024943.3)
40SP140n/a
n/a
n/a
n/a
n/achr2 230,269,475SP140 nuclear body protein, transcript variant 1 (from RefSeq NM_007237.5)
41ENSG00000268027n/a
n/a
n/a
n/a
n/achr19 41,550,221ENSG00000268027 (from geneSymbol)
42LINC02422n/a
    
    
     
n/achr12 31,918,142long intergenic non-protein coding RNA 2422 (from HGNC LINC02422)
43TASLn/a
    
    
     
n/achrX 30,568,287TLR adaptor interacting with endolysosomal SLC15A4 (from RefSeq NM_025159.3)
44NCR3n/a
n/a
n/a
n/a
n/achr6 31,590,950natural cytotoxicity triggering receptor 3, transcript variant 1 (from RefSeq NM_147130.3)
45SCIMPn/a
n/a
n/a
n/a
n/achr17 5,221,890SLP adaptor and CSK interacting membrane protein, transcript variant 1 (from RefSeq NM_207103.3)
46ITGADn/a
    
    
     
n/achr16 31,409,920integrin subunit alpha D, transcript variant 2 (from RefSeq NM_005353.3)
47ENSG00000260757n/a
    
    
     
n/achr16 31,403,632ENSG00000260757 (from geneSymbol)
48NCAPGn/a
n/a
n/a
n/a
n/achr4 17,827,922non-SMC condensin I complex subunit G, transcript variant 1 (from RefSeq NM_022346.5)
49ENSG00000271680n/a
    
    
     
n/achr1 206,906,160ENSG00000271680 (from geneSymbol)
50IGLV9-49n/a
    
    
     
n/achr22 22,343,459V region of the variable domain of immunoglobulin light  chains that participates in the antigen recognition (PubMed:24600447).  Immunoglobulins, also known as antibodies, are membrane-bound or  secreted glycoproteins produced by B lymphocytes. In the recognition  phase of humoral immunity, the membrane-bound immunoglobulins serve as  receptors which, upon binding of a specific antigen, trigger the clonal  expansion and differentiation of B lymphocytes into immunoglobulins-  secreting plasma cells. Secreted immunoglobulins mediate the effector  phase of humoral immunity, which results in the elimination of bound  antigens (PubMed:20176268, PubMed:22158414). The antigen binding site  is formed by the variable domain of one heavy chain, together with that  of its associated light chain. Thus, each immunoglobulin has two  antigen binding sites with remarkable affinity for a particular  antigen. The variable domains are assembled by a process called V-(D)-J  rearrangement and can then be subjected to somatic hypermutations  which, after exposure to antigen and selection, allow affinity  maturation for a particular antigen (PubMed:17576170, PubMed:20176268). (from UniProt A0A0B4J1Y8)